Just let me know the rules for Phuket.
Anyway protein based vaccines are gonna hit the market Q3 Q4 and be evaluated. Sanofi got one in the pipeline as well.
If you can survive an encounter with a ladyboy, COVID is nothing.
I intend to ride into town with a ladyboy escort.
Send a pic lol
You’re posting in the right thread. But I have some bad news for you and your ladyboy escort.
But that’s good news. I’m over 55 so I reckon I’ll be vaccinated sometime in July.
I’m not far from your grouping. We’ve got 3.5 million 65+ senior citizens ahead of us. And this isn’t counting the various groups in front of them and the people who will use guanxi to jump ahead. It’s still possible but it will take some big, positive news of vaccine imports in the coming weeks. I think it will happen but if it doesn’t, I think July is VERY optimistic.
I got a feeling we is gonna be swimming in vaccines.
Your list is not complete.
Japan gives us 40 million, we’re all good.
They give us that I’ll forgive them for the rape of Nanking.
Actually laughed out loud, not sure if that is more a reflection on me or on your comment…
Yeah it’s a bit edgy.
They’re people too, and at high risk of spreading Covid. They also go shopping and have families. The more vaccinated, the better. If we count those who were vaxed today, by now we should have over 2% of the population vaxed.
Most govt bureaucrats have no good reason to get my second dose. Messed up.
Why on earth should the EU or its member countries give vaccination status to people with the Taiwanese vaccine? If they are approved by EU/WHO yes, else no. They will almost certainly not spend any resources on researching this question and Sputnik is also clearly not considered vaccinated even though Sputnik even managed to get an article into Lancet
Some of the numbers from the UK, the US and the EU:
The MHRA has received:
382 UK reports of suspected ADRs to the Pfizer/BioNTech vaccine in which the patient died shortly after vaccination,
806 reports for the COVID-19 Vaccine AstraZeneca,
4 for the COVID-19 Vaccine Moderna and 21 where the brand of vaccine was unspecified.
Unsolicited Adverse Events
Reports of lymphadenopathy were imbalanced with 58 more cases in the vaccine group (64) than the placebo group (6); lymphadenopathy is plausibly related to the vaccine.
Serious Adverse Event
The proportions of participants who reported at least 1 serious adverse event were 0.6% in the vaccine group and 0.5% in the placebo group. The most common serious adverse events in the vaccine group which were numerically higher than in the placebo group were appendicitis (7 in vaccine vs 2 in placebo), acute myocardial infarction (3 vs 0), and cerebrovascular accident (3 vs 1). Cardiovascular serious adverse events were balanced between vaccine and placebo groups. Two serious adverse events were considered by U.S. Food and Drug Administration (FDA) as possibly related to vaccine: shoulder injury possibly related to vaccine administration or to the vaccine itself, and lymphadenopathy involving the axilla contralateral to the vaccine injection site.
This site gives an overview of all the side effects across countries.
Pfizer-BioNTech and Moderna
Yet many were alarmed by reports from Norway that 23 people had died shortly after receiving the Pfizer-BioNTech vaccine. However, there is no evidence that these deaths were a direct result of the vaccine.
Another death, which occurred in the U.S., was associated with having a low blood platelet count, or thrombocytopenia. So far, 20 thrombocytopenia cases have developed following either a Pfizer or Moderna vaccination. Currently, however, no causal evidence links these cases with the vaccines.
Janssen (Johnson & Johnson)
Following reports of eight cases of thrombosis with thrombocytopenia syndrome (TTS), a rare and severe blood clotting disorder and low blood platelet counts, the CDC and the FDA briefly recommended pausing the distribution of the Janssen COVID-19 vaccine in April 2021.
After conducting a safety review, the two federal agencies lifted the recommended pause, concluding that the vaccine’s “known and potential benefits outweigh its known and potential risks in individuals 18 years of age and older” and that the risk of TTS after vaccination was “very low.”
Oxford-AstraZeneca and Serum Institute of India
Of the 5 million people who received this vaccine, there have been 30 reported cases of blood clots. One case in Denmark was followed by death. On April 7, 2021, the EMA concluded that the Oxford-AstraZeneca vaccine should carry a warning of TTS as a very rare side effect. Multiple countries, including Denmark, Norway, Germany, and France, initially paused the distribution of the Oxford-AstraZeneca COVID-19 vaccine as a precautionary response to initial reports of blood clots. On April 14, 2021, Denmark decided to stop the distribution of this vaccine entirely. On April 15, the Norwegian Institute of Public Health recommended stopping the distribution of both the Oxford-AstraZeneca and Janssenvaccines in the country, due to the risk of blood clots.
It seems like Pfizer/BNT and Moderna might cause thrombocytopenia but people just stopped looking into it. Janssen and AZ might cause thrombosis or thrombocytopenia, and they were monitored far more closely?
Some big announcements tomorrow, Wednesday.